Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands?
OBJECTIVE
We hypothesize that sex steroids induce sex-specific and/or opposite effects in the lacrimal and meibomian glands and that these actions may influence the prevalence of dry eye syndrome. The objective of this study was to begin to test this hypothesis.


METHODS
Lacrimal and meibomian glands were obtained from ovariectomized mice that had been treated with testosterone or control vehicle for 14 days. Samples were processed for the isolation of RNA, and analyzed for differentially expressed mRNAs using CodeLink Bioarrays and quantitative real-time PCR (qPCR) techniques. Data were compared to those obtained following testosterone treatment of orchiectomized mice, as well as after the administration of 17beta-estradiol and/or progesterone to ovariectomized mice.


RESULTS
Our findings demonstrate that testosterone regulates the expression of thousands of genes in the lacrimal and meibomian glands of ovariectomized mice. The magnitude and extent of these hormonal effects, which encompassed numerous biological, molecular, and cellular ontologies, was tissue-dependent. Particularly notable was the androgen stimulation of meibomian gland genes related to lipid metabolic pathways, and the suppression of genes associated with keratinization. Many of the genes regulated by testosterone in female tissues were identical to those controlled by androgens in male lacrimal and meibomian glands. However, some genes were modulated in a sex-specific manner. In addition, a number of the androgen-regulated genes in female glands were altered in the opposite direction by 17beta-estradiol and/or progesterone.


CONCLUSIONS
Our results support our hypothesis that sex steroids may induce sex-specific and/or opposite effects in the lacrimal and meibomian glands. Whether these actions contribute to the prevalence of dry eye remains to be determined.
Sullivan
David A
DA
Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114, USA. david.sullivan@schepens.harvard.edu
Jensen
Roderick V
RV
Suzuki
Tomo
T
Richards
Stephen M
SM
D000818:Animals; D019070:Cell Lineage / Q000187:drug effects / Q000235:genetics; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D012739:Gonadal Steroid Hormones / Q000494:pharmacology*; D007765:Lacrimal Apparatus / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D008537:Meibomian Glands / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D010052:Ovariectomy; D011374:Progesterone / Q000494:pharmacology; D015203:Reproducibility of Results; D012727:Sex Characteristics; D013739:Testosterone / Q000494:pharmacology
D012739:Gonadal Steroid Hormones; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol
Adv Exp Med Biol. 2002;506(Pt A):137-41
12613900
J Invest Dermatol. 1962 Aug;39:139-55
13917704
Cornea. 1996 May;15(3):229-34
8713923
Endocrinol Metab Clin North Am. 2003 Mar;32(1):195-218
12699299
J Appl Physiol (1985). 2006 Oct;101(4):1252-61
16794020
Exp Eye Res. 2002 Nov;75(5):561-71
12457868
Cutis. 1982 Aug;30(2):212-4, 216-7, 219 passim
6215213
Physiol Rev. 1989 Apr;69(2):383-416
2648418
Neuroendocrinology. 2003 Apr;77(4):258-72
12766326
Transpl Int. 2002 Oct;15(9-10):494-501
12389082
Rheum Dis Clin North Am. 2000 Nov;26(4):825-39
11084946
Cell Mol Life Sci. 2002 Oct;59(10):1714-23
12475182
J Invest Dermatol. 1974 Mar;62(3):191-201
4361985
Infection. 2002 Aug;30(4):229-33
12236567
Arch Dermatol Res. 1980;268(3):277-81
7212772
J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S87-94
11511858
JAMA. 2001 Nov 7;286(17):2114-9
11694152
J Neuroendocrinol. 2009 Mar;21(4):400-5
19356199
Cornea. 1991 Jul;10(4):277-85
1889213
Br J Dermatol. 2006 Jan;154(1):21-7
16403089
Am J Ophthalmol. 2003 Aug;136(2):318-26
12888056
J Endocrinol. 1969 Nov;45(3):421-4
5358268
Endocr Rev. 2000 Aug;21(4):363-92
10950157
Genome Biol. 2003;4(1):R7
12540299
Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3732-42
11053270
Cornea. 2003 Aug;22(6):516-21
12883343
Acta Ophthalmol Scand. 2000 Apr;78(2):146-53
10794246
Heart Lung Circ. 2007 Jun;16(3):185-92
17448726
Nat Genet. 2000 May;25(1):25-9
10802651
Mol Endocrinol. 1990 Apr;4(4):657-67
2280780
Arch Ophthalmol. 1995 Oct;113(10):1266-70
7575257
Curr Eye Res. 1996 Mar;15(3):279-91
8654108
J Steroid Biochem Mol Biol. 2005 Sep;96(5):401-13
16006120
Hum Reprod Update. 2000 May-Jun;6(3):225-36
10874567
J Clin Invest. 1998 Mar 15;101(6):1300-9
9502771
Ocul Surf. 2007 Apr;5(2):179-93
17508121
J Invest Dermatol. 1972 Oct;59(4):299-304
4652619
J Steroid Biochem Mol Biol. 1993 Dec;46(6):737-49
8274407
J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):189-96
16621515
Arch Oral Biol. 2007 Jun;52(6):507-17
17174266
J Clin Endocrinol Metab. 2000 Dec;85(12):4866-73
11134155
Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2632-42
8163351
J Rheumatol. 2003 Nov;30(11):2413-9
14677186
Immunology. 1984 Jun;52(2):239-46
6735436
J Invest Dermatol. 1996 Jul;107(1):44-50
8752838
Br J Ophthalmol. 2000 Jan;84(1):76-84
10611104
Neuroscience. 2008 Jun 2;153(4):1268-77
18434028
Endocrinology. 2009 Mar;150(3):1235-49
18974276
Biochem Biophys Res Commun. 2006 Mar 24;341(4):1286-93
16469299
Invest Ophthalmol Vis Sci. 1991 Oct;32(11):3002-6
1917404
Clin Immunol Immunopathol. 1989 Dec;53(3):499-508
2805454
Am J Physiol. 1997 May;272(5 Pt 1):L844-51
9176247
J Invest Dermatol. 1969 Jul;53(1):8-10
5793140
Blood. 2003 Oct 1;102(7):2653-9
12791649
Adv Physiol Educ. 2007 Mar;31(1):26-33
17327579
J Rheumatol. 2002 Nov;29(11):2382-5
12415596
Maturitas. 2001 Jan 31;37(3):209-12
11173183
Biochim Biophys Acta. 2006 Apr;1763(4):381-92
16713447
Cornea. 2002 Oct;21(7 Suppl):S70-4
12484702
Adv Exp Med Biol. 2002;506(Pt A):449-58
12613945
Exp Eye Res. 2006 Jan;82(1):13-23
15979613
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3666-75
16186348
Br J Dermatol. 1980 Aug;103(2):139-42
6448623
FASEB J. 2008 Aug;22(8):2676-89
18390925
Steroids. 2008 Oct;73(9-10):953-60
18249430
Arch Dermatol Res. 1985;277(3):230-4
4015185
Arch Dermatol. 1976 Aug;112(8):1108-9
952527
Curr Opin Pharmacol. 2005 Dec;5(6):626-32
16185926
Arch Ophthalmol. 2009 Jun;127(6):763-8
19506195
J Steroid Biochem Mol Biol. 1994 Feb;48(2-3):165-70
8142291
Exp Eye Res. 2006 Aug;83(2):291-6
16579987
J Invest Dermatol. 1989 May;92(5):769-73
2715647
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):158-68
16384958
Clin Exp Immunol. 1997 Sep;109(3):555-61
9328136
J Steroid Biochem Mol Biol. 1999 Sep-Oct;70(4-6):151-8
10622403
Ocul Surf. 2004 Apr;2(2):92-123
17216082
Semin Reprod Med. 2009 May;27(3):229-39
19401954
Arch Ophthalmol. 2006 Sep;124(9):1286-92
16966624
Am J Ophthalmol. 1982 Sep;94(3):383-7
7124880
Isr Med Assoc J. 2002 Dec;4(12):1101-5
12516900
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1192-201
8125730
Biochem Int. 1985 Feb;10(2):129-35
3873241
Curr Eye Res. 2007 May;32(5):393-8
17514523
Invest Ophthalmol Vis Sci. 2008 May;49(5):1797-808
18436814
Surv Ophthalmol. 1996 Mar-Apr;40(5):343-67
8779082
J Clin Endocrinol Metab. 2000 Dec;85(12):4874-82
11134156
Arch Ophthalmol. 2002 Dec;120(12):1689-99
12470144
Immunol Res. 2005;31(2):91-106
15778508
Exp Eye Res. 1995 Dec;61(6):659-66
8846837
Arch Dermatol Res. 1983;275(3):175-80
6614993